» Articles » PMID: 12464175

Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing During T Lymphocyte Development

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Dec 5
PMID 12464175
Citations 336
Authors
Affiliations
Soon will be listed here.
Abstract

T lymphocytes differentiate in discrete stages within the thymus. Immature thymocytes lacking CD4 and CD8 coreceptors differentiate into double-positive cells (CD4(+)CD8(+)), which are selected to become either CD4(+)CD8(-)helper cells or CD4(-)CD8(+) cytotoxic cells. A stage-specific transcriptional silencer regulates expression of CD4 in both immature and CD4(-)CD8(+) thymocytes. We show here that binding sites for Runt domain transcription factors are essential for CD4 silencer function at both stages, and that different Runx family members are required to fulfill unique functions at each stage. Runx1 is required for active repression in CD4(-)CD8(-) thymocytes whereas Runx3 is required for establishing epigenetic silencing in cytotoxic lineage thymocytes. Runx3-deficient cytotoxic T cells, but not helper cells, have defective responses to antigen, suggesting that Runx proteins have critical functions in lineage specification and homeostasis of CD8-lineage T lymphocytes.

Citing Articles

T Cell Development: From T-Lineage Specification to Intrathymic Maturation.

Golzari-Sorkheh M, Yoganathan K, Chen E, Singh J, Zuniga-Pflucker J Adv Exp Med Biol. 2025; 1471:81-137.

PMID: 40067585 DOI: 10.1007/978-3-031-77921-3_4.


The unique functions of Runx1 in skeletal muscle maintenance and regeneration are facilitated by an ETS interaction domain.

Yu M, Thorner K, Parameswaran S, Wei W, Yu C, Lin X Development. 2024; 151(24).

PMID: 39508441 PMC: 11664167. DOI: 10.1242/dev.202556.


Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators.

Huang J, Xiong L, Tang S, Zhao J, Zuo L Int J Mol Sci. 2024; 25(20).

PMID: 39456702 PMC: 11507008. DOI: 10.3390/ijms252010919.


Sexually Dimorphic Response to Hepatic Injury in Newborn Suffering from Intrauterine Growth Restriction.

Wei Y, Tang W, Mao P, Mao J, Ni Z, Hou K Adv Sci (Weinh). 2024; 11(30):e2403095.

PMID: 38867614 PMC: 11321654. DOI: 10.1002/advs.202403095.


PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape.

Gamble N, Bradu A, Caldwell J, McKeever J, Bolonduro O, Ermis E Nat Immunol. 2024; 25(5):860-872.

PMID: 38632339 PMC: 11089574. DOI: 10.1038/s41590-024-01807-y.